News on immunoassay systems and applications.
Bio-Rad's PCR-based test is designed to detect SARS-CoV-2 nucleic acid, while United Biomedical's test detects antibodies against the virus.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
Compared with RT-PCR testing, Abbott's BinaxNow test had a sensitivity of 64 percent for samples from symptomatic people and nearly 36 percent for asymptomatic people.
Actim said the assay has 96 percent sensitivity and 98 percent specificity and it does not cross-react with IgG antibodies against other common viruses.
Released by the Pandemic Response Accountability Committee, the report looks at data on test volume, turnaround, cost, and usage at six federal agencies.
